FHIR IG analytics| Package | hl7.fhir.uv.xver-r4.r4b.r4b |
| Resource Type | ValueSet |
| Id | ValueSet-R4-research-study-phase-for-R4B.json |
| FHIR Version | R4B |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet R4-research-study-phase-for-R4B
This value set expansion contains 4 concepts.
| Code | System | Display | Definition |
| early-phase-1 | http://terminology.hl7.org/CodeSystem/research-study-phase | Early Phase 1 | Designation for optional exploratory trials conducted in accordance with the United States Food and Drug Administration's (FDA) 2006 Guidance on Exploratory Investigational New Drug (IND) Studies. Formerly called Phase 0. |
| phase-1-phase-2 | http://terminology.hl7.org/CodeSystem/research-study-phase | Phase 1/Phase 2 | Trials that are a combination of phases 1 and 2. |
| phase-2-phase-3 | http://terminology.hl7.org/CodeSystem/research-study-phase | Phase 2/Phase 3 | Trials that are a combination of phases 2 and 3. |
| phase-4 | http://terminology.hl7.org/CodeSystem/research-study-phase | Phase 4 | Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use. |
FHIR
FHIRsmith{
"resourceType": "ValueSet",
"id": "R4-research-study-phase-for-R4B",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 1
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "brr"
},
{
"extension": [
{
"url": "packageId",
"valueId": "hl7.fhir.uv.xver-r4.r4b"
},
{
"url": "version",
"valueString": "0.0.1-snapshot-2"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/4.0/ImplementationGuide/hl7.fhir.uv.xver-r4.r4b"
}
]
}
}
],
"url": "http://hl7.org/fhir/4.0/ValueSet/R4-research-study-phase-for-R4B",
"version": "0.0.1-snapshot-2",
"name": "R4_research_study_phase_for_R4B",
"title": "Cross-version VS for R4.ResearchStudyPhase for use in FHIR R4B",
"status": "active",
"experimental": false,
"date": "2025-09-01T22:36:17.026093+10:00",
"publisher": "Biomedical Research and Regulation",
"contact": [
{
"name": "Biomedical Research and Regulation",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/rcrim"
}
]
}
],
"description": "This cross-version ValueSet represents concepts from http://hl7.org/fhir/ValueSet/research-study-phase|4.0.1 for use in FHIR R4B. Concepts not present here have direct `equivalent` mappings crossing all versions from R4 to R4B.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"compose": {
"include": [
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"concept": [
{
"code": "early-phase-1",
"display": "Early Phase 1"
},
{
"code": "phase-1-phase-2",
"display": "Phase 1/Phase 2"
},
{
"code": "phase-2-phase-3",
"display": "Phase 2/Phase 3"
},
{
"code": "phase-4",
"display": "Phase 4"
}
]
}
]
},
"expansion": {
"timestamp": "2025-09-01T22:36:17.026097+10:00",
"contains": [
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "early-phase-1",
"display": "Early Phase 1"
},
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "phase-1-phase-2",
"display": "Phase 1/Phase 2"
},
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "phase-2-phase-3",
"display": "Phase 2/Phase 3"
},
{
"system": "http://terminology.hl7.org/CodeSystem/research-study-phase",
"version": "4.0.1",
"code": "phase-4",
"display": "Phase 4"
}
]
}
}